Access Statistics for Christopher James Sampson

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Framework for Value-aligned Pricing of Combination Therapies 0 0 1 6 2 3 9 19
Barriers to Uptake of Minimal Access Surgery in the United Kingdom 0 0 0 2 0 2 13 25
Cost implications of treatment non-completion in a forensic personality disorder service 0 0 0 15 0 1 18 61
Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation? 0 0 0 9 2 3 14 42
Happy and healthy: a joint model of health and life satisfaction 0 0 0 87 0 1 15 302
How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy 0 0 0 29 2 3 16 111
How is Quality of Life Measured for Health Technology Assessments? 0 1 1 17 1 3 22 64
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C 0 0 0 1 0 0 10 15
The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe 0 0 1 7 2 3 13 28
The Impact of New Medicines in the NHS: 70 Years of Innovation 0 0 0 1 1 1 5 13
The impact of inflation on incremental costs in HTA 0 0 9 9 1 7 22 22
The relationship between individual risk and cost-effectiveness in screening interventions 0 0 0 43 2 4 14 306
The value of cell and gene therapies to the UK economy 0 1 1 1 6 11 14 14
Total Working Papers 0 2 13 227 19 42 185 1,022
4 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469–776 0 0 0 3 1 2 16 98
Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al 0 0 0 1 0 0 9 16
Is anchoring at ‘dead’ a theoretical requirement for health state valuation? 0 0 0 1 1 1 14 20
Marginal cost per QALY estimates: What are they good for? 0 1 2 12 1 2 21 64
Model Registration: A Call to Action 0 0 0 4 1 1 8 71
NICE and the EQ-5D-5L: Ten Years Trouble 0 0 1 4 0 1 8 27
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy 0 0 8 29 2 3 42 155
Transparency in Decision Modelling: What, Why, Who and How? 0 0 0 4 2 2 14 70
Total Journal Articles 0 1 11 58 8 12 132 521


Statistics updated 2026-11-12